The global fundus camera market was valued at $445.60 million in 2020, and is estimated to reach $710.20 million by 2030, growing at a CAGR of 4.50% from 2021 to 2030.
A fundus camera is a specialized device that combines a low-power microscope with an attached camera to monitor the fundus portion. Its optical design is inspired by an indirect ophthalmoscope. The fundus camera takes images of the back of the eye, which is known as the fundus. The fundus is made up of ten semi-transparent layers, each of which serves a specific purpose in the visual perception process. The central and peripheral retina, optic disc, and macula are the principal structures seen using a fundus camera.
The indirect ophthalmoscope is the foundation of the fundus camera. It is commonly utilized in fluorescein angiography, external photography, paired optic disc imaging, and fundus imaging. It's also utilized to diagnose retinal problems such glaucoma, retinal detachment, diabetic retinopathy, and age-related macular degeneration.
Furthermore, sales of the fundus camera decreased temporarily in 2020 due to limited access to ophthalmic treatment. In addition, rising rates of mucormycosis as a result of COVID-19 comorbidity necessitate an assessment of each patient's eye health. However, individuals may require long-term monitoring for any ocular issues that arise following post COVID-19 recovery. This is predicted to increase the patients in ophthalmology departments, necessitating the purchase of more diagnostic equipment such as fundus cameras, as ophthalmologists now rely on handheld fundus cameras to keep a safe distance from patients.
The prevalence of diabetes retinopathy, cataract, conjunctivitis, retinal disorders and age-relate macular degeneration are said to increase with the rising ageing population. In addition, findings also reveals that children are also more prone to develop eye disorders such as glaucoma, conjunctivitis and night blindness among others. Vision loss due to eye diseases is a major health problem, which immensely affects the quality of life.
Vision loss is the third largest cause of impairment after anaemia and hearing loss. As per the sciencedirect, in 2020, across the globe approximately 38.5 million people were registered as blind. Cataract is the other most commonly observed eye disorder that is found in the developing nations were the access to the qualified professionals are less. Therefore, the cataract is responsible for more than 50% of the cases of blindness in some of the areas which is likely to increase the demand for the ophthalmologists to grow. Thus, owing to the above mentioned factors the market for the fundus camera is likely to grow in the coming future.
Increasing geriatric population has resulted in higher prevalence of age-related macular degeneration (AMD). Furthermore, rising incidence of diabetic retinopathy is expected to increase demand for ophthalmic screening devices, subsequently driving demand for nonmydriatic handheld fundus cameras.
As per the laws and regulations by various medical devices agencies in U.S. as well as Japan, fundus imaging cameras must be replaced once in every four years. Therefore, demand for these devices is likely to increase in these developed countries in the forecast years. Supportive government regulations such as these are likely to have a positive impact on the fundus camera market.
Approximately 80% cases of blindness due to chronic diseases can be avoided by continuous and effective screening. Screening is the only way of detecting eye diseases at an early stage. In U.S., fundus photography procedures are covered by Medicare under CPT code 92250. Growing insurance coverage for such procedures is also likely to boost demand for handheld fundus camera.
Furthermore, the growing prevalence of age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma is driving the fundus camera market. Fundus camera technological improvements such as hybrid cameras, non-mydriatic cameras, and hand-held fundus cameras are also driving the fundus cameras market. Furthermore, higher healthcare expenditure and rising awareness about eye problems present opportunities for the fundus cameras market in the forecast years. However, issues with the use of fundus cameras as well as a lack of awareness are the major factors restraining the growth of the fundus cameras market.
The global fundus camera market is segmented on the basis of product, portability, end user and region. By product, the market is categorized into mydriatic fundus cameras, non-mydriatic fundus cameras, hybrid fundus cameras, and rop fundus cameras. By portability, the market is bifurcated into handheld and tabletop. By end user, it is divided into hospital, ophthalmology clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific and LAMEA.
Some of the major companies that operate in the global fundus camera market are Carl Zeiss Meditec AG, Kowa Company, Ltd., Optomed Plc, Optovue Incorporated, Topcon Corporation, Clarity Medical Systems, Inc., Canon Inc., Epipole Ltd, Revenio Group Corporation (Centervue SPA), and Clarity Medical Systems, Inc.
A fundus camera is a specialized device that combines a low-power microscope with an attached camera to monitor the fundus portion. Its optical design is inspired by an indirect ophthalmoscope. The fundus camera takes images of the back of the eye, which is known as the fundus. The fundus is made up of ten semi-transparent layers, each of which serves a specific purpose in the visual perception process. The central and peripheral retina, optic disc, and macula are the principal structures seen using a fundus camera.
The indirect ophthalmoscope is the foundation of the fundus camera. It is commonly utilized in fluorescein angiography, external photography, paired optic disc imaging, and fundus imaging. It's also utilized to diagnose retinal problems such glaucoma, retinal detachment, diabetic retinopathy, and age-related macular degeneration.
Furthermore, sales of the fundus camera decreased temporarily in 2020 due to limited access to ophthalmic treatment. In addition, rising rates of mucormycosis as a result of COVID-19 comorbidity necessitate an assessment of each patient's eye health. However, individuals may require long-term monitoring for any ocular issues that arise following post COVID-19 recovery. This is predicted to increase the patients in ophthalmology departments, necessitating the purchase of more diagnostic equipment such as fundus cameras, as ophthalmologists now rely on handheld fundus cameras to keep a safe distance from patients.
The prevalence of diabetes retinopathy, cataract, conjunctivitis, retinal disorders and age-relate macular degeneration are said to increase with the rising ageing population. In addition, findings also reveals that children are also more prone to develop eye disorders such as glaucoma, conjunctivitis and night blindness among others. Vision loss due to eye diseases is a major health problem, which immensely affects the quality of life.
Vision loss is the third largest cause of impairment after anaemia and hearing loss. As per the sciencedirect, in 2020, across the globe approximately 38.5 million people were registered as blind. Cataract is the other most commonly observed eye disorder that is found in the developing nations were the access to the qualified professionals are less. Therefore, the cataract is responsible for more than 50% of the cases of blindness in some of the areas which is likely to increase the demand for the ophthalmologists to grow. Thus, owing to the above mentioned factors the market for the fundus camera is likely to grow in the coming future.
Increasing geriatric population has resulted in higher prevalence of age-related macular degeneration (AMD). Furthermore, rising incidence of diabetic retinopathy is expected to increase demand for ophthalmic screening devices, subsequently driving demand for nonmydriatic handheld fundus cameras.
As per the laws and regulations by various medical devices agencies in U.S. as well as Japan, fundus imaging cameras must be replaced once in every four years. Therefore, demand for these devices is likely to increase in these developed countries in the forecast years. Supportive government regulations such as these are likely to have a positive impact on the fundus camera market.
Approximately 80% cases of blindness due to chronic diseases can be avoided by continuous and effective screening. Screening is the only way of detecting eye diseases at an early stage. In U.S., fundus photography procedures are covered by Medicare under CPT code 92250. Growing insurance coverage for such procedures is also likely to boost demand for handheld fundus camera.
Furthermore, the growing prevalence of age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma is driving the fundus camera market. Fundus camera technological improvements such as hybrid cameras, non-mydriatic cameras, and hand-held fundus cameras are also driving the fundus cameras market. Furthermore, higher healthcare expenditure and rising awareness about eye problems present opportunities for the fundus cameras market in the forecast years. However, issues with the use of fundus cameras as well as a lack of awareness are the major factors restraining the growth of the fundus cameras market.
The global fundus camera market is segmented on the basis of product, portability, end user and region. By product, the market is categorized into mydriatic fundus cameras, non-mydriatic fundus cameras, hybrid fundus cameras, and rop fundus cameras. By portability, the market is bifurcated into handheld and tabletop. By end user, it is divided into hospital, ophthalmology clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific and LAMEA.
Some of the major companies that operate in the global fundus camera market are Carl Zeiss Meditec AG, Kowa Company, Ltd., Optomed Plc, Optovue Incorporated, Topcon Corporation, Clarity Medical Systems, Inc., Canon Inc., Epipole Ltd, Revenio Group Corporation (Centervue SPA), and Clarity Medical Systems, Inc.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global fundus camera market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global fundus camera market to predict the competitive environment across regions.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region & country-wise analysis is provided to understand the fundus camera market trends and dynamics.
KEY MARKET SEGMENTS
By Product
- Mydriatic Fundus Cameras
- Non-Mydriatic Fundus Cameras
- Hybrid Fundus Cameras
- ROP Fundus Cameras
By Portability
- Handheld
- Tabletop
By End User
- Hospitals
- Ophthalmology Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
KEY MARKET PLAYERS
- Carl Zeiss Meditec AG
- Kowa Company, Ltd.
- Optomed Plc
- Optovue Incorporated
- Topcon Corporation
- Clarity Medical Systems, Inc.
- Canon Inc.
- Epipole Ltd
- Revenio Group Corporation (Centervue SPA)
- Clarity Medical Systems, Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Top player positioning
3.4. Market dynamics
3.4.1. Drivers, restraints, and opportunity
3.4.2. Drivers
3.4.2.1. Increasing prevalence of chronic eye diseases
3.4.2.2. Supportive Government Regulations
3.4.3. Restraints
3.4.3.1. High costs of fundus camera
3.4.3.2. Lack of awareness, low access to eye care in low-income economies
3.4.4. Opportunity
3.4.4.1. Increasing strategic alliances and awareness regarding retinal disorder
3.5. Impact of COVID-19 on intravenous infusion pump market
3.5.1. Overview
3.5.2. Impact analysis
CHAPTER 4: FUNDUS CAMERA MARKET, BY PRODUCT4.1. Overview
4.1.1. Market size and forecast
4.2. Mydriatic Fundus Cameras
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Non-Mydriatic Fundus Cameras
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Hybrid Fundus Cameras
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. ROP Fundus Cameras
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: FUNDUS CAMERA MARKET, BY PORTABILITY5.1. Overview
5.1.1. Market size and forecast
5.2. Hand-Held
5.2.1. Key market trends and growth opportunities
5.2.2. Market size and forecast
5.2.3. Market analysis, by country
5.3. Table-Top
5.3.1. Key market trends and growth opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country
CHAPTER 6: FUNDUS CAMERA MARKET, BY END USER6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.2.2.1. Market size and forecast for hospitals, by portability
6.3. Ophthalmology Clinics
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.3.2.1. Market size and forecast for ophthalmology clinics , by portability
6.4. Others
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.4.2.1. Market size and forecast for others, by portability
CHAPTER 7: FUNDUS CAMERA MARKET, BY REGION7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key opportunities and forecast
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by product
7.2.4. Market size and forecast, by portability
7.2.5. Market size and forecast, by end user
7.2.5.1. Market size and forecast for hospitals, by portability
7.2.5.2. Market size and forecast for ophthalmology clinics, by portability
7.2.5.3. Market size and forecast for others, by portability
7.2.5.4. U.S.
7.2.5.4.1. U.S. market size and forecast, by Product
7.2.5.4.2. U.S. market size and forecast, by portability
7.2.5.4.3. U.S. market size and forecast, by end user
7.2.5.5. Canada
7.2.5.5.1. Canada market size and forecast, by Product
7.2.5.5.2. Canada market size and forecast, by portability
7.2.5.5.3. Canada market size and forecast, by end user
7.2.5.6. Mexico
7.2.5.6.1. Mexico market size and forecast, by product
7.2.5.6.2. Mexico market size and forecast, by portability
7.2.5.6.3. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key opportunities and forecast
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by product
7.3.4. Market size and forecast, by portability
7.3.5. Market size and forecast, by end user
7.3.5.1. Market size and forecast for hospitals, by portability
7.3.5.2. Market size and forecast for ophthalmology clinics, by portability
7.3.5.3. Market size and forecast for others, by portability
7.3.5.4. Germany
7.3.5.4.1. Germany market size and forecast, by Product
7.3.5.4.2. Germany market size and forecast, by portability
7.3.5.4.3. Germany market size and forecast, by end user
7.3.5.5. France
7.3.5.5.1. France market size and forecast, by Product
7.3.5.5.2. France market size and forecast, by portability
7.3.5.5.3. France market size and forecast, by end user
7.3.5.6. UK
7.3.5.6.1. UK market size and forecast, by Product
7.3.5.6.2. UK market size and forecast, by portability
7.3.5.6.3. UK market size and forecast, by end user
7.3.5.7. Italy
7.3.5.7.1. Italy market size and forecast, by Product
7.3.5.7.2. Italy market size and forecast, by portability
7.3.5.7.3. Italy market size and forecast, by end user
7.3.5.8. Spain
7.3.5.8.1. Spain market size and forecast, by Product
7.3.5.8.2. Spain market size and forecast, by portability
7.3.5.8.3. Spain market size and forecast, by end user
7.3.5.9. Rest of Europe
7.3.5.9.1. Rest of Europe market size and forecast, by Product
7.3.5.9.2. Rest of Europe market size and forecast, by portability
7.3.5.9.3. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key opportunities and forecast
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by product
7.4.4. Market size and forecast, by portability
7.4.5. Market size and forecast, by end user
7.4.5.1. Market size and forecast for hospitals, by portability
7.4.5.2. Market size and forecast for ophthalmology clinics, by portability
7.4.5.3. Market size and forecast for others, by portability
7.4.5.4. Japan
7.4.5.4.1. Japan market size and forecast, by Product
7.4.5.4.2. Japan market size and forecast, by portability
7.4.5.4.3. Japan market size and forecast, by end user
7.4.5.5. China
7.4.5.5.1. China market size and forecast, by Product
7.4.5.5.2. China market size and forecast, by portability
7.4.5.5.3. China market size and forecast, by end user
7.4.5.6. Australia
7.4.5.6.1. Australia market size and forecast, by Product
7.4.5.6.2. Australia. market size and forecast, by portability
7.4.5.6.3. Australia market size and forecast, by end user
7.4.5.7. India
7.4.5.7.1. India market size and forecast, by Product
7.4.5.7.2. India market size and forecast, by portability
7.4.5.7.3. India market size and forecast, by end user
7.4.5.8. Rest of Asia-Pacific
7.4.5.8.1. Rest of Asia-Pacific market size and forecast, by Product
7.4.5.8.2. Rest of Asia-Pacific market size and forecast, by portability
7.4.5.8.3. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key opportunities and forecast
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by product
7.5.4. Market size and forecast, by portability
7.5.5. Market size and forecast, by end user
7.5.5.1. Market size and forecast for hospitals, by portability
7.5.5.2. Market size and forecast for ophthalmology clinics, by portability
7.5.5.3. Market size and forecast for others, by portability
7.5.5.4. Brazil
7.5.5.4.1. Brazil market size and forecast, by Product
7.5.5.4.2. Brazil market size and forecast, by portability
7.5.5.4.3. Brazil market size and forecast, by end user
7.5.5.5. Saudi Arabia
7.5.5.5.1. Saudi Arabia market size and forecast, by Product
7.5.5.5.2. Saudi Arabia market size and forecast, by portability
7.5.5.5.3. Saudi Arabia market size and forecast, by end user
7.5.5.6. South Africa
7.5.5.6.1. South Africa market size and forecast, by Product
7.5.5.6.2. South Africa market size and forecast, by portability
7.5.5.6.3. South Africa market size and forecast, by end user
7.5.5.7. Rest of LAMEA
7.5.5.7.1. Rest of LAMEA market size and forecast, by Product
7.5.5.7.2. Rest of LAMEA market size and forecast, by portability
7.5.5.7.3. Rest of LAMEA market size and forecast, by end user
List of Tables
TABLE 01. FUNDUS CAMERA MARKET REVENUE, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 02. FUNDUS CAMERA MARKET REVENUE FOR MYDRIATIC FUNDUS CAMERAS, BY REGION, 2020-2030 ($MILLION)
TABLE 03. FUNDUS CAMERA MARKET REVENUE FOR NON-MYDRIATIC FUNDUS CAMERAS, BY REGION, 2020-2030($MILLION)
TABLE 04. FUNDUS CAMERA MARKET REVENUE FOR HYBRID FUNDUS CAMERAS, BY REGION, 2020-2030 ($MILLION)
TABLE 05. FUNDUS CAMERA MARKET REVENUE FOR ROP FUNDUS CAMERAS, BY REGION, 2020-2030 ($MILLION)
TABLE 06. FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030 ($MILLION)
TABLE 07. HAND-HELD FUNDUS CAMERA MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 08. TABLE-TOP FUNDUS CAMERA MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09. FUNDUS CAMERA MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 10. FUNDUS CAMERA MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
TABLE 11. FUNDUS CAMERA MARKET FOR HOSPITALS, BY PORTABILITY, 2020-2030 ($MILLION)
TABLE 12. FUNDUS CAMERA MARKET FOR OPHTHALMOLOGY CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. FUNDUS CAMERA MARKET FOR OPHTHALMOLOGY CLINICS, BY PORTABILITY, 2020-2030 ($MILLION)
TABLE 14. FUNDUS CAMERA MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 15. FUNDUS CAMERA MARKET FOR OTHERS, BY PORTABILITY, 2020-2030 ($MILLION)
TABLE 16. FUNDUS CAMERA MARKET, BY REGION, 2020-2030($MILLION)
TABLE 17. NORTH AMERICA FUNDUS CAMERA MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 18. NORTH AMERICA FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 19. NORTH AMERICA FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 20. NORTH AMERICA FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 21. NORTH AMERICA FUNDUS CAMERA MARKET FOR HOSPITALS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 22. NORTH AMERICA FUNDUS CAMERA MARKET FOR OPHTHALMOLOGY CLINICS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 23. NORTH AMERICA FUNDUS CAMERA MARKET FOR OTHERS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 24. U.S. FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 25. U.S. FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 26. U.S. FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 27. CANADA FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 28. CANADA FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 29. CANADA FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 30. MEXICO FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 31. MEXICO. FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 32. MEXICO FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 33. EUROPE FUNDUS CAMERA MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 34. EUROPE FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 35. EUROPE FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 36. EUROPE FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 37. EUROPE FUNDUS CAMERA MARKET FOR HOSPITALS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 38. EUROPE FUNDUS CAMERA MARKET FOR OPHTHALMOLOGY CLINICS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 39. EUROPE FUNDUS CAMERA MARKET FOR OTHERS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 40. GERMANY FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 41. GERMANY. FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 42. GERMANY FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 43. FRANCE FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 44. FRANCE FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 45. FRANCE FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 46. UK FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 47. UK FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 48. UK FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 49. ITALY FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 50. ITALY FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 51. ITALY. FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 52. SPAIN FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 53. SPAIN FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 54. SPAIN FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 55. REST OF EUROPE FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 56. REST OF EUROPE FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 57. REST OF EUROPE FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 58. ASIA-PACIFIC FUNDUS CAMERA MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 59. ASIA-PACIFIC FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 60. ASIA-PACIFIC FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 61. ASIA-PACIFIC FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 62. ASIA-PACIFIC FUNDUS CAMERA MARKET FOR HOSPITALS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 63. ASIA-PACIFIC FUNDUS CAMERA MARKET FOR OPHTHALMOLOGY CLINICS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 64. ASIA-PACIFIC FUNDUS CAMERA MARKET FOR OTHERS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 65. JAPAN FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 66. JAPAN FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 67. JAPAN FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 68. CHINA FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 69. CHINA FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 70. CHINA FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 71. AUSTRALIA FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 72. AUSTRALIA FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 73. AUSTRALIA FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 74. INDIA FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 75. INDIA FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 76. INDIA FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 77. REST OF ASIA-PACIFIC FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 78. REST OF ASIA-PACIFIC FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 79. REST OF ASIA-PACIFIC FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 80. LAMEA FUNDUS CAMERA MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 81. LAMEA FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 82. LAMEA FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 83. LAMEA FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 84. LAMEA FUNDUS CAMERA MARKET FOR HOSPITALS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 85. LAMEA FUNDUS CAMERA MARKET FOR OPHTHALMOLOGY CLINICS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 86. LAMEA FUNDUS CAMERA MARKET FOR OTHERS, BY PORTABILITY, 2020-2030($MILLION)
TABLE 87. BRAZIL FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 88. BRAZIL FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 89. BRAZIL FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 90. SAUDI ARABIA FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 91. SAUDI ARABIA FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 92. SAUDI ARABIA FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 93. SOUTH AFRICA FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 94. SOUTH AFRICA FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 95. SOUTH AFRICA FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
TABLE 96. REST OF LAMEA FUNDUS CAMERA MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 97. REST OF LAMEA FUNDUS CAMERA MARKET, BY PORTABILITY, 2020-2030($MILLION)
TABLE 98. REST OF LAMEA FUNDUS CAMERA MARKET, BY END USER, 2020-2030($MILLION)
List of Figures
FIGURE 01. FUNDUS CAMERA MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MODERATE BARGAINING POWER OF BUYERS
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. MODERATE THREAT OF SUBSTITUTION
FIGURE 07. MODERATE COMPETITIVE RIVALRY
FIGURE 08. TOP PLAYER POSITIONING, 2020
FIGURE 09. DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 10. FUNDUS CAMERA MARKET REVENUE FOR MYDRIATIC FUNDUS CAMERAS, BY COUNTRY, 2020-2030 (%)
FIGURE 11. FUNDUS CAMERA MARKET REVENUE FOR NON-MYDRIATIC FUNDUS CAMERAS, BY COUNTRY, 2020-2030(%)
FIGURE 12. FUNDUS CAMERA MARKET REVENUE FOR HYBRID FUNDUS CAMERAS, BY COUNTRY, 2020-2030(%)
FIGURE 13. FUNDUS CAMERA MARKET REVENUE FOR ROP FUNDUS CAMERAS, BY COUNTRY, 2020-2030(%)
FIGURE 14. COMPARATIVE ANALYSIS OF HAND-HELD FUNDUS CAMERA MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF TABLE-TOP FUNDUS CAMERA MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF FUNDUS CAMERA MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF FUNDUS CAMERA MARKET FOR OPHTHALMOLOGY CLINICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF FUNDUS CAMERA MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
Companies Mentioned
- Carl Zeiss Meditec AG
- Kowa Company Ltd.
- Optomed Plc
- Optovue Incorporated
- Topcon Corporation
- Clarity Medical Systems Inc.
- Canon Inc.
- Epipole Ltd
- Revenio Group Corporation (Centervue SPA)
- Clarity Medical Systems Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 187 |
| Published | August 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 445.6 million |
| Forecasted Market Value ( USD | $ 710.2 million |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
